FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2163421 · Received July 15, 2011

Report

Report Number
2124215-2011-07212
Event Type
Injury
Date Received
July 15, 2011
Date of Event
April 22, 2011
Report Date
April 26, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
PMA / PMN Number
P910073
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

WHEN ADDITIONAL INFORMATION IS RECEIVED, THIS EVENT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

AS NO RETURN OF PRODUCT IS INTENDED, THEREFORE THIS CLINICAL ALLEGATION CANNOT BE CONFIRMED OR DENIED. NO FURTHER INFORMATION IS EXPECTED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS EVENT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A FOLLOW UP VISIT, THIS RIGHT VENTRICULAR LEAD DISPLAYED NOISE AND OVERSENSING. AS THE PATIENT HAD RECEIVED INAPPROPRIATE SHOCK THERAPY, IT WAS THOUGHT THIS WAS DUE TO A LEAD FRACTURE. IMPEDANCE MEASUREMENTS HAVE INCREASED SINCE IMPLANT, BUT REMAIN WITHIN ACCEPTABLE RANGE. SHOCK IMPEDANCE MEASUREMENTS WERE WITHIN NORMAL LIMITS. NOISE WAS ONLY NOTED ON THE VENTRICULAR AND NOT THE SHOCK CHANNEL. ISOMETRIC MANEUVERS REPRODUCED THE NOISE. THE PATIENT WITH THIS LEAD IS NOT PACEMAKER DEPENDANT. A REVISION TO IMPLANT ANOTHER PACE/SENSE LEAD IS INTENDED IN THE NEAR FUTURE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED. A REVISION PROCEDURE WAS PERFORMED. AN ADDITIONAL PACE/SENSE RIGHT VENTRICULAR LEAD WAS IMPLANTED. THE PACE/SENSE PORTION OF THIS LEAD WAS SURGICALLY CAPPED AND ABANDONED. DEFIBRILLATION TESTING WAS PERFORMED SUCCESSFULLY. THE VENTRICULAR TACHYCARDIA WAS CONVERTED APPROPRIATELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0175

Patients

Seq Age Sex Outcome Treatment
1 Other